Weaker US jobs data has pulled Treasury yields lower, which can make smaller companies look more attractive as investors search beyond the largest stocks. That is where the Financially Fit Penny Stocks screener comes in. It filters for lower-priced shares with healthier balance sheets so you are not just chasing stories. This article highlights three screened stocks that stand out on financial quality and potential resilience.

The three stocks covered below are only a small sample of the opportunities that screened well, and the full Financially Fit Penny Stocks search surfaced 324 more companies with similar financial characteristics and story potential that are not featured in this article. If you want to go broader and identify your own higher conviction ideas, head straight to the Financially Fit Penny Stocks screener to filter, analyze, and focus on the penny stocks that best match your approach.

Ardelyx (ARDX)

Ardelyx is a US based biopharmaceutical company focused on treating irritable bowel syndrome with constipation through IBSRELA and managing high phosphorus levels in chronic kidney disease patients on dialysis through XPHOZAH. These products target clear unmet medical needs in gastroenterology and kidney care. The stock currently carries a market cap of about US$997 million.

Ardelyx sits at the intersection of growing kidney and gastrointestinal treatment demand and a stock price that reflects both promise and controversy. Product revenue reached US$118 million in Q2 2026, helped by IBSRELA and XPHOZAH, yet the company still reported a net loss and has withdrawn its longer term US$750 million revenue target. Investor interest is fuelled by analyst expectations for earnings and margin improvement, and by the company’s push to reach sustainable profitability in 2027. At the same time, heavy reliance on tenapanor based drugs, reimbursement setbacks with Medicare for XPHOZAH, insider selling and meaningful debt costs mean the risk side of the ledger cannot be ignored.

Ardelyx sits at a crossroads where rising product revenue, pulled guidance and tight reimbursement questions all collide. To see how this mix of promise and pressure stacks up, review the 4 key rewards and 1 important warning sign

Build your own Ardelyx style penny stock shortlist

Ardelyx and the two other stocks in this article all came from a single Simply Wall St screener, which is only a starting point. Use our flexible Screener to mix filters like valuation, future growth and balance sheet strength, or jump straight into any of our curated Investing Ideas for ready made shortlists.

Taboola.com (TBLA)

Taboola.com runs an AI powered recommendation platform that sits on publisher sites, devices and apps to match readers with content and ads across the open web. Almost all of its US$2.0b in revenue comes from advertising services through this single business line, with exposure across the US, Israel, Europe and the rest of the world. The stock currently has a market cap of about US$1.1b.

Taboola.com sits at an interesting crossroads for anyone watching how AI is changing digital advertising. The company is leaning into tools like Realize and DeeperDive and has turned recent results into profits, yet forecasts point to only modest earnings growth and a possible swing back to losses within a few years. A low P/E multiple, strong governance and heavy share buybacks are pulling in some investors, while dependence on publisher partnerships, slower revenue growth and questions about long term open web traffic keep others cautious.

Taboola.com’s low P/E, substantial share buybacks and AI-focused initiatives may appear to signal an inflection point that the market has not fully recognized. Get the fuller story and the key risk twist in the analysis report for Taboola.com

Hyliion Holdings (HYLN)

Hyliion Holdings is a US based power technology company developing the fuel flexible KARNO Power Module for distributed electricity generation across data centers, defense and other heavy power users. The business currently reports about US$6 million in revenue from Auto Parts & Accessories in the US and has a market cap of roughly US$690 million.

Hyliion Holdings is drawing attention because the KARNO platform sits at the intersection of growing on site power needs, clean generation goals and fuel flexibility, backed by recent multi megawatt US Navy contracts worth about US$42 million each and early revenue progress. At the same time, the company is still loss making, relies on a cash runway of less than a year and is priced above some estimated future cash flow values, so execution on commercialization and cost control is important. For investors willing to consider an early stage story with promising technology and meaningful contract wins, there is more to unpack in Hyliion’s balance between high growth ambitions and real financing and delivery risks.

Hyliion Holdings sits at the crossroads of early revenue, multi megawatt US Navy contracts, and a tight cash runway, which makes the next execution steps crucial. Get the full context in the analysis report for Hyliion Holdings

Seeking Fresh Alternatives Before They Fly

Fresh stock ideas do not stay under the radar for long. Once momentum builds, the best entry points can be gone. Scan these curated shortlists now and look for opportunities early.

• Spot companies with strong cash flows and solid balance sheets before they attract wider attention by running the 52 high quality undervalued stocks.
• Explore the growing demand for automation and next generation manufacturing by screening focused 37 robotics and automation stocks that match your risk and growth preferences.
• Review a curated set of 37 power grid technology and infrastructure stocks that may be relevant as infrastructure spending priorities evolve.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.